BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/22/2015 2:02:00 PM | Browse: 1017 | Download: 1755
 |
Received |
|
2014-11-25 20:07 |
|
Peer-Review Started |
|
2014-11-26 10:15 |
|
To Make the First Decision |
|
2015-01-08 16:56 |
|
Return for Revision |
|
2015-01-13 08:42 |
|
Revised |
|
2015-02-13 11:05 |
|
Second Decision |
|
2015-03-29 10:08 |
|
Accepted by Journal Editor-in-Chief |
|
2015-03-30 11:34 |
|
Accepted by Company Editor-in-Chief |
|
2015-04-28 18:08 |
|
Articles in Press |
|
2015-04-28 18:09 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2015-06-08 05:31 |
|
Typeset the Manuscript |
|
2015-07-06 09:38 |
|
Publish the Manuscript Online |
|
2015-07-22 13:58 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Chao-Jie Wang, Zi-Zhen Zhang, Jia Xu, Ming Wang, Wen-Yi Zhao, Lin Tu, Chun Zhuang, Qiang Liu, Yan-Yin Shen, Hui Cao and Zhi-Gang Zhang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81272743 |
| Shanghai City Committee of Science and Technology Key Project |
11411950800 |
| Key Discipline Project of Renji Hospital, Shanghai Jiaotong University School of Medicine |
RJ4101304 |
|
| Corresponding Author |
Hui Cao, MD, Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dong fang Road, Shanghai 200127, China. caohuimedsci@126.com |
| Key Words |
SLITRK3; Gastrointestinal stromal tumor; Biomarkers; Non-epithelial tumors; Risk stratification |
| Core Tip |
Prognostic biomarkers are required to refine risk stratification treatment strategies for gastrointestinal stromal tumor (GIST). In this study, we hypothesized that SLIT and NTRK-like family member 3 (SLITRK3) could be used as a prognostic molecular biomarker for GIST. The results indicated that SLITRK3 expression is a highly significant predictor of GIST recurrence and metastasis. Combinations of SLITRK3 and NIH stage have strong predictive and prognostic value, and are feasible markers for clinical practice in gastrointestinal stromal tumor.
|
| Publish Date |
2015-07-22 13:58 |
| Citation |
Wang CJ, Zhang ZZ, Xu J, Wang M, Zhao WY, Tu L, Zhuang C, Liu Q, Shen YY, Cao H, Zhang ZG. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis. World J Gastroenterol 2015; 21(27): 8398-8407 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i27/8398.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i27.8398 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
